GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Wanjia Group Holdings Ltd (HKSE:00401) » Definitions » Median PS Value

Wanjia Group Holdings (HKSE:00401) Median PS Value : HK$0.08 (As of May. 15, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Wanjia Group Holdings Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Wanjia Group Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.316. Wanjia Group Holdings's 10-Year median PS Ratio is 0.2532. Therefore, the Median PS Value for today is HK$0.08.

As of today (2024-05-15), Wanjia Group Holdings's share price is HK$0.085. Wanjia Group Holdings's Median PS Value is HK$0.08. Therefore, Wanjia Group Holdings's Price to Median PS Value for today is 1.06.

The historical rank and industry rank for Wanjia Group Holdings's Median PS Value or its related term are showing as below:

HKSE:00401' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.88   Med: 2.25   Max: 2.25
Current: 1.06

During the past 11 years, the highest Price to Median PS Value of Wanjia Group Holdings was 2.25. The lowest was 0.88. And the median was 2.25.

HKSE:00401's Price-to-Median-PS-Value is ranked worse than
65.45% of 55 companies
in the Medical Distribution industry
Industry Median: 0.94 vs HKSE:00401: 1.06

Wanjia Group Holdings Median PS Value Historical Data

The historical data trend for Wanjia Group Holdings's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanjia Group Holdings Median PS Value Chart

Wanjia Group Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.08

Wanjia Group Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.08 -

Competitive Comparison of Wanjia Group Holdings's Median PS Value

For the Medical Distribution subindustry, Wanjia Group Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanjia Group Holdings's Price-to-Median-PS-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Wanjia Group Holdings's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Wanjia Group Holdings's Price-to-Median-PS-Value falls into.



Wanjia Group Holdings Median PS Value Calculation

Wanjia Group Holdings's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.316*0.2532
=0.08

10-Year Median PS Ratio is 0.2532.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wanjia Group Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.316.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanjia Group Holdings  (HKSE:00401) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Wanjia Group Holdings's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.085/0.08
=1.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanjia Group Holdings Median PS Value Related Terms

Thank you for viewing the detailed overview of Wanjia Group Holdings's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanjia Group Holdings (HKSE:00401) Business Description

Traded in Other Exchanges
N/A
Address
25 Canton Road, Harbour City, Suite 1801, 18th Floor, Tower 1, The Gateway, Kowloon, Hong Kong, HKG
Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business.

Wanjia Group Holdings (HKSE:00401) Headlines

No Headlines